Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cremer

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Klinische Wochenschrift|May 15, 1975
[Further investigations on cellular immunodeficiency in uraemic patients and the effect of haemodialysis (author's transl)]H E Reis, W Cremer, V H Heimsoth, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Detoxification treatment in chronic digitalis poisoning in dogs using hemocol perfusion]K O Bischoff, N Graben, E Flohr, et al.
Cancer Genetics and Cytogenetics|October 11, 2005
Chromosomal aberrations in follicular non-Hodgkin lymphomas of Japanese patients, detected with comparative genomic hybridization and polymerase chain reaction analysisJan G D'Haese, Kunihiro Tsukasaki, Friedrich W Cremer, et al.
Deutsche Medizinische Wochenschrift (1946)|January 7, 1977
[Permeability of dialysis membranes for hepatitis-B virus: on the prophylaxis of hepatitis in a haemodialysis centre (author's transl)]N Scheiermann, O Thraenhart, R Dermietzel, et al.
Bone Marrow Transplantation|June 30, 1998
First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yieldK Kiel, F W Cremer, E Ehrbrecht, et al.
Molecular Genetics and Metabolism|November 26, 2009
A 439 kb-sized homozygous deletion in 17p13.3 leading to biallelic loss of the ASPA as cause of Canavan disease detected by SNP-array analysisA Caliebe, I Vater, H Plendl, et al.
Leukemia|January 22, 1998
A rationale for positive selection of peripheral blood stem cells in multiple myeloma: highly purified CD34+ cell fractions of leukapheresis products do not contain malignant cellsF W Cremer, K Kiel, C Sucker, et al.
Bone Marrow Transplantation|November 18, 2000
Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myelomaF W Cremer, E Ehrbrecht, K Kiel, et al.
British Journal of Haematology|August 25, 1999
Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantationC Rottenburger, K Kiel, T Bösing, et al.
Leukemia|July 29, 2000
CD19+ and CD20+ B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8T Bösing, F Bellos, F W Cremer, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Klinische Wochenschrift|May 15, 1975
[Further investigations on cellular immunodeficiency in uraemic patients and the effect of haemodialysis (author's transl)]H E Reis, W Cremer, V H Heimsoth, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Detoxification treatment in chronic digitalis poisoning in dogs using hemocol perfusion]K O Bischoff, N Graben, E Flohr, et al.
Cancer Genetics and Cytogenetics|October 11, 2005
Chromosomal aberrations in follicular non-Hodgkin lymphomas of Japanese patients, detected with comparative genomic hybridization and polymerase chain reaction analysisJan G D'Haese, Kunihiro Tsukasaki, Friedrich W Cremer, et al.
Deutsche Medizinische Wochenschrift (1946)|January 7, 1977
[Permeability of dialysis membranes for hepatitis-B virus: on the prophylaxis of hepatitis in a haemodialysis centre (author's transl)]N Scheiermann, O Thraenhart, R Dermietzel, et al.
Bone Marrow Transplantation|June 30, 1998
First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yieldK Kiel, F W Cremer, E Ehrbrecht, et al.
Molecular Genetics and Metabolism|November 26, 2009
A 439 kb-sized homozygous deletion in 17p13.3 leading to biallelic loss of the ASPA as cause of Canavan disease detected by SNP-array analysisA Caliebe, I Vater, H Plendl, et al.
Leukemia|January 22, 1998
A rationale for positive selection of peripheral blood stem cells in multiple myeloma: highly purified CD34+ cell fractions of leukapheresis products do not contain malignant cellsF W Cremer, K Kiel, C Sucker, et al.
Bone Marrow Transplantation|November 18, 2000
Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myelomaF W Cremer, E Ehrbrecht, K Kiel, et al.
British Journal of Haematology|August 25, 1999
Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantationC Rottenburger, K Kiel, T Bösing, et al.
Leukemia|July 29, 2000
CD19+ and CD20+ B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8T Bösing, F Bellos, F W Cremer, et al.
Pageof 8